Cargando…

DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway

SIMPLE SUMMARY: Dickkopf-related protein 1 (DKK1) plays different roles in different cancers, and its aberrant expression is associated with tumor progression and poor prognosis. However, the role of DKK1 in gastric cancer is not well studied or understood, especially regarding its function in gastr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian, Zhang, Yaqiong, Ye, Fangzhou, Qian, Peiyu, Qin, Zhe, Li, Deming, Ye, Li, Feng, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571993/ https://www.ncbi.nlm.nih.gov/pubmed/37835450 http://dx.doi.org/10.3390/cancers15194756

Ejemplares similares

CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling Pathway
por: Zang, Mingde, et al.
Publicado: (2014)

LINC01268 promotes epithelial-mesenchymal transition, invasion and metastasis of gastric cancer via the PI3K/Akt signaling pathway and targeting MARCKS
por: Tang, Ling-Han, et al.
Publicado: (2023)

ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway
por: Ye, Jianxin, et al.
Publicado: (2017)

Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3
por: Li, Yuling, et al.
Publicado: (2022)

Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
por: Li, Jiang, et al.
Publicado: (2023)

Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways
por: Li, Wenfeng, et al.
Publicado: (2022)

MT1G inhibits the growth and epithelial-mesenchymal transition of gastric cancer cells by regulating the PI3K/AKT signaling pathway
por: Xu, Guofeng, et al.
Publicado: (2022)

Telocinobufagin inhibits the epithelial-to-mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway
por: Gao, Yuxue, et al.
Publicado: (2021)

TRAF4 Regulates Migration, Invasion, and Epithelial–Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma
por: Liu, Kairui, et al.
Publicado: (2017)

α-Mangostin Suppresses the Viability and Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells by Downregulating the PI3K/Akt Pathway
por: Xu, Qinhong, et al.
Publicado: (2014)

The PI3K-AKT-mTOR signaling pathway mediates the cytoskeletal remodeling and epithelial-mesenchymal transition in bladder outlet obstruction
por: Zhang, Zhaoxia, et al.
Publicado: (2023)

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling
por: Wang, Yan, et al.
Publicado: (2018)

HSPC159 promotes proliferation and metastasis by inducing epithelial‐mesenchymal transition and activating the PI3K/Akt pathway in breast cancer
por: Zheng, Jie, et al.
Publicado: (2018)

PD-L1 Induces Epithelial–Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway
por: Fei, Zhenghua, et al.
Publicado: (2019)

CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer
por: Chen, Binshen, et al.
Publicado: (2020)

Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
por: Tian, Xiangdong, et al.
Publicado: (2018)

miR-193a Directly Targets PSEN1 and Inhibits Gastric Cancer Cell Growth, the Activation of PI3K/Akt Signaling Pathway, and the Epithelial-to-Mesenchymal Transition
por: Pan, Xuemei, et al.
Publicado: (2021)

OCF can repress tumor metastasis by inhibiting epithelial–mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells
por: Yang, Ye, et al.
Publicado: (2017)

MiR-185-3p regulates epithelial mesenchymal transition via PI3K/Akt signaling pathway by targeting cathepsin D in gastric cancer cells
por: Huang, Cheng, et al.
Publicado: (2020)

CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling
por: Liu, Zhao, et al.
Publicado: (2018)

FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC
por: Zhou, Fengrui, et al.
Publicado: (2019)

Hsa_circ_0030586 promotes epithelial–mesenchymal transition in prostate cancer via PI3K-AKT signaling
por: Luo, Guang-Cheng, et al.
Publicado: (2021)

PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)

Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway
por: Luo, Xue, et al.
Publicado: (2022)

Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway
por: Yeh, Yen-Hsiu, et al.
Publicado: (2018)

lncRNA H19 is involved in TGF-β1-induced epithelial to mesenchymal transition in bovine epithelial cells through PI3K/AKT Signaling Pathway
por: Yang, Wei, et al.
Publicado: (2017)

UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer
por: Cui, Ping, et al.
Publicado: (2022)

TGM3 functions as a tumor suppressor by repressing epithelial-to-mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer
por: Feng, Yifei, et al.
Publicado: (2020)

Thidiazuron decreases epithelial‐mesenchymal transition activity through the NF‐kB and PI3K/AKT signalling pathways in breast cancer
por: Rajendran, Peramaiyan, et al.
Publicado: (2020)

Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma
por: Feng, Ying-Nan, et al.
Publicado: (2022)

Agmatine Alleviates Cisplatin-Induced Ototoxicity by Activating PI3K/AKT Signaling Pathway
por: Zhang, Ying, et al.
Publicado: (2022)

GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial-mesenchymal transition through PI3K/AKT signaling activation
por: Ji, Bing, et al.
Publicado: (2018)

Rotenone restrains colon cancer cell viability, motility and epithelial-mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway
por: Xiao, Wenbo, et al.
Publicado: (2020)

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
por: Dong, Peixin, et al.
Publicado: (2014)

TRIM59 induces epithelial-to-mesenchymal transition and promotes migration and invasion by PI3K/AKT signaling pathway in medulloblastoma
por: Gao, Ran, et al.
Publicado: (2018)

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2017)

TOP2A Promotes Cell Migration, Invasion and Epithelial–Mesenchymal Transition in Cervical Cancer via Activating the PI3K/AKT Signaling
por: Wang, Bi, et al.
Publicado: (2020)

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
por: Dai, Qingqiang, et al.
Publicado: (2020)

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
por: Xu, Qiuran, et al.
Publicado: (2017)

Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation
por: Li, Can, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eme0i34bllbge1fa4nfu3frn0v